Christoph Pittius (Past Speaker)

Christoph Pittius is SVP, Research Business Development at City of Hope and is based in Mölndal, Sweden. Prior to joining City of Hope, he was the Head of Transactions, AstraZeneca Business Development, where he and his team focused on negotiating global strategic in- and out-licensing deals of clinical-stage and on-the-market product opportunities as well as M&A in AstraZeneca’s core indications of interest. Christoph was also in Senior Business Development roles at Novartis, Boehringer Ingelheim and Hoechst (now Sanofi) in the US and Germany, and also worked at a New York City based Investment Bank. Christoph’s original training was as a biochemist and molecular biologist, obtained at the Max-Planck Institute for Psychiatry, Munich, Germany.